Dr. Jorge Vidal was trained and also worked in Cellular Microbiology, Bacterial Genetics and Global Molecular Epidemiology throughout his Post-Doc, Masters and Ph.D at RSPH. He leads a research unit focused on investigating diseases caused by S. pneumonia and other globally important bacterial respiratory pathogens. He is also a visiting researcher of the respiratory diseases branch at the Centers for Disease Control and Prevention as well as holds adjunct faculty positions at the Emory’s Population Biology Ecology and Evolution (PBEE) graduate program and other graduate International programs based in Mexico. He has experience in diagnostic methods including traditional and molecular methods. This technology is utilized in our epidemiological studies and clinical trials evaluating, for example, new antimicrobials to treat bacterial pneumonia or sinusitis. His work with S. pneumoniae, one of the most important killers of children in the world, is focused on dissecting the way they persist in the human nasopharynx, how they regulate persistence, and the impact of pneumococcal vaccination on carriage and antibiotic resistance. These studies are complemented with translational science, population-based studies and basic science approaches including studies of biofilm formation on human respiratory cells and mechanism(s) of antibiotic resistance. His research programs are currently studying human respiratory pathogens (e.g. S. pneumoniae, S. aureus, H. influenzae, N. meningitidis, etc.) affecting both developed and resource-poor countries.
Bacterial pathogenesis and Molecular epidemiology.